Logo

Scientist/ Senior Scientist

by / 0 Comments / 0 View / February 1, 2017 12:49 PM

Immunocore Limited, just south of Oxford, UK, is an innovative and dynamic biotechnology company developing a unique platform of T Cell antigen receptor-based therapeutics, called ImmTACs, as a novel class of treatments for cancer. Having recently entered into four major partnerships with Genentech, GlaxoSmithKline, MedImmune and Eli Lilly, and with our first drug candidate in clinical trials as well as a pipeline of TCRs to follow, we are seeking to strengthen our Development group by appointi…

Source:: Nature